Hancock Jaffe Laboratories, Inc. logo
Hancock Jaffe Laboratories, Inc. HJLI

Hancock Jaffe Laboratories, Inc. Revenue 2011-2026 | HJLI

Company revenue is the total amount of money received from the sale of goods or services over a certain period of time. It is one of the key indicators of a company's financial condition and success.

Traditionally defined as follows:
Revenue = Price * Quantity of products

Revenue is one of the components of a company’s income. In international practice, revenue is understood as the inflow or other increase in a company's assets or the settlement of its obligations that occurs as a result of the company’s core or main activity.[1]

This is an important indicator for assessing the financial condition and efficiency of a company. It makes it possible to determine how successfully a company sells its products or services on the market. In addition, revenue can be used to calculate other financial indicators such as profit, profitability, and market share.

Various factors can influence this indicator, including demand for goods or services, market competition, economic conditions, and the company's marketing efforts. Therefore, its analysis and monitoring are important tasks for the successful development of a business.

Annual Revenue Hancock Jaffe Laboratories, Inc.

2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
4.25 K 31.2 K 187 K 422 K 786 K - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
786 K 4.25 K 286 K

References

  1. Adhikari, B. (2010). Impact of Revenue Planning In Nepal Investment Bank Limited (Doctoral dissertation, Faculty of Management).

Revenue of other stocks in the Medical devices industry

Issuer Revenue Price % 24h Market Cap Country
Penumbra Penumbra
PEN
1.4 B $ 335.9 0.49 % $ 13.1 B usaUSA
BioSig Technologies BioSig Technologies
BSGM
40 K - 37.08 % $ 85.7 M usaUSA
GenMark Diagnostics, Inc. GenMark Diagnostics, Inc.
GNMK
172 M - - $ 1.77 B usaUSA
Axonics Modulation Technologies Axonics Modulation Technologies
AXNX
274 M - - $ 3.31 B usaUSA
Aziyo Biologics Aziyo Biologics
AZYO
12.3 M - 1.37 % $ 20.5 M usaUSA
Acutus Medical Acutus Medical
AFIB
7.16 M - -26.83 % $ 2.62 M usaUSA
Insulet Corporation Insulet Corporation
PODD
2.71 B $ 220.08 -2.4 % $ 15.5 B usaUSA
Allied Healthcare Products Allied Healthcare Products
AHPI
6.02 M - 3.58 % $ 2.21 M usaUSA
Obalon Therapeutics, Inc. Obalon Therapeutics, Inc.
OBLN
1.59 M - -5.86 % $ 30.6 M usaUSA
Second Sight Medical Products Second Sight Medical Products
EYES
1 K - -0.97 % $ 54.4 M usaUSA
Profound Medical Corp. Profound Medical Corp.
PROF
7.2 M $ 5.69 10.49 % $ 180 M canadaCanada
Quanterix Corporation Quanterix Corporation
QTRX
139 M $ 3.97 3.93 % $ 169 M usaUSA
Conformis Conformis
CFMS
62 M - - $ 16.4 M usaUSA
AVITA Medical AVITA Medical
RCEL
71.6 M $ 3.98 3.65 % $ 111 M australiaAustralia
IRIDEX Corporation IRIDEX Corporation
IRIX
51.9 M $ 1.34 -1.11 % $ 21.6 M usaUSA
IRadimed Corporation IRadimed Corporation
IRMD
83.8 M $ 102.42 1.44 % $ 1.3 B usaUSA
Cardiovascular Systems Cardiovascular Systems
CSII
236 M - 0.15 % $ 844 M usaUSA
Apollo Endosurgery Apollo Endosurgery
APEN
76.9 M - - $ 475 M usaUSA
Avinger Avinger
AVGR
7.65 M - -20.74 % $ 369 K usaUSA
CryoLife, Inc. CryoLife, Inc.
CRY
253 M - -4.14 % $ 702 M usaUSA
Sintx Technologies Sintx Technologies
SINT
1.02 M $ 2.6 0.97 % $ 7.21 M usaUSA
CONMED Corporation CONMED Corporation
CNMD
1.37 B $ 36.85 0.72 % $ 1.14 B usaUSA
Smith & Nephew plc Smith & Nephew plc
SNN
4.56 B $ 32.43 0.82 % $ 23.8 B britainBritain
Sensus Healthcare Sensus Healthcare
SRTS
27.5 M $ 4.18 5.56 % $ 68.2 M usaUSA
Itamar Medical Ltd. Itamar Medical Ltd.
ITMR
41 M - 0.03 % $ 1.58 B israelIsrael
NanoVibronix NanoVibronix
NAOV
2.56 M - - $ 1.08 M usaUSA
Electromed Electromed
ELMD
64 M $ 24.83 0.53 % $ 210 M usaUSA
Misonix, Inc. Misonix, Inc.
MSON
62.5 M - - $ 462 M usaUSA
Neovasc Neovasc
NVCN
2.55 M - - $ 111 M canadaCanada
Tactile Systems Technology Tactile Systems Technology
TCMD
330 M $ 27.05 0.71 % $ 619 M usaUSA
TELA Bio TELA Bio
TELA
58.5 M $ 0.69 -9.35 % $ 15.8 M usaUSA
Intersect ENT, Inc. Intersect ENT, Inc.
XENT
80.6 M - - $ 955 M usaUSA
Tandem Diabetes Care Tandem Diabetes Care
TNDM
290 M $ 24.5 -0.04 % $ 1.67 B usaUSA
Cytosorbents Corporation Cytosorbents Corporation
CTSO
35.6 M $ 0.67 -4.17 % $ 36.5 M usaUSA
Aethlon Medical Aethlon Medical
AEMD
574 K $ 2.36 9.26 % $ 3.68 M usaUSA
BIOLASE BIOLASE
BIOL
49.2 M - -13.19 % $ 166 K usaUSA
Orthofix Medical Orthofix Medical
OFIX
822 M $ 11.84 0.98 % $ 469 M curacaoCuracao
InspireMD InspireMD
NSPR
8.98 M $ 1.76 -1.68 % $ 113 M israelIsrael
AdaptHealth Corp. AdaptHealth Corp.
AHCO
3.24 B $ 11.35 -1.13 % $ 1.53 B usaUSA
Myomo Myomo
MYO
40.9 M $ 0.7 -1.07 % $ 29.3 M usaUSA
Nano-X Imaging Ltd. Nano-X Imaging Ltd.
NNOX
1.3 M $ 2.3 -4.38 % $ 135 M israelIsrael
Invacare Corporation Invacare Corporation
IVC
181 M - - $ 24.7 M usaUSA
EDAP TMS S.A. EDAP TMS S.A.
EDAP
44.1 M $ 3.72 -4.86 % $ 139 M franceFrance
OrthoPediatrics Corp. OrthoPediatrics Corp.
KIDS
236 M $ 16.29 2.36 % $ 382 M usaUSA
Outset Medical Outset Medical
OM
119 M $ 3.53 - $ 53.7 K usaUSA
Varex Imaging Corporation Varex Imaging Corporation
VREX
845 M $ 10.71 0.85 % $ 443 M usaUSA